Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Vertex Pharmaceuticals 3.334, Henry Schein 3.458.
Vertex Pharmaceuticals vs Henry Schein: Revenue Comparison
Vertex Pharmaceuticals (VRTX) and Henry Schein (HSIC) are peers in Healthcare. Vertex Pharmaceuticals reported revenue of $3.3B as of Q2 2026, compared with $3.5B for Henry Schein. Henry Schein leads on revenue.
Vertex Pharmaceuticals's gross margin is 85.3% versus 31.8% for Henry Schein. Vertex Pharmaceuticals's net margin is 33.0% versus 2.7% for Henry Schein.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Vertex Pharmaceuticals, Henry Schein.| Metric | Vertex Pharmaceuticals | Henry Schein |
|---|---|---|
| Market Cap | - | - |
| Revenue | $3.33B | $3.46B |
| Cost of Revenue | $489.00M | $2.36B |
| Gross Profit | $2.85B | $1.10B |
| Operating Income | $1.25B | $200.00M |
| Net Income | $1.10B | $94.00M |
| R&D Expense | $994.00M | $0 |
| Earnings Per Share | $4.31 | $0.82 |
| Gross Margin | 85.3% | 31.8% |
| Operating Margin | 37.4% | 5.8% |
| Net Profit Margin | 33.0% | 2.7% |
| Free Cash Flow | $1.01B | $196.00M |
| Cumulative Free Cash Flow | $17.24B | $9.89B |
| Operating Cash Flow | $1.13B | $242.00M |
| Cash & Equivalents | $6.14B | $157.00M |